New York State Common Retirement Fund Mirati Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

$75.8 Billion
Q1 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$41.99 - $62.38 $11.6 Million - $17.3 Million	-277,401 Reduced 87.34%	40,200 $2.36 Million
Q3 2023 Nov 07, 2023	BUY	$27.8 - $45.35 $2.36 Million - $3.84 Million	84,741 Added 36.39%	317,601 $13.8 Million
Q2 2023 Aug 07, 2023	BUY	$36.13 - $49.49 $23,231 - $31,822	643 Added 0.28%	232,860 $8.41 Million
Q1 2023 May 02, 2023	BUY	$36.54 - $54.26 $30,510 - $45,307	835 Added 0.36%	232,217 $8.63 Million
Q4 2022 Jan 30, 2023	BUY	$41.27 - $98.62 $2.09 Million - $5 Million	50,650 Added 28.02%	231,382 $10.5 Million

Q3 2022 Nov 08, 2022	SELL	$59.5 - $86.7 $95,795 - $139,587	-1,610 Reduced 0.88%	180,732 $12.6 Million
Q2 2022 Aug 04, 2022	BUY	$39.16 - $88.71 $2.47 Million - $5.59 Million	63,059 Added 52.87%	182,342 $12.2 Million
Q1 2022 May 05, 2022	BUY	$75.82 - $150.97 $4.89 Million - $9.73 Million	64,480 Added 117.66%	119,283 $9.81 Million
Q4 2021 Feb 02, 2022	BUY	$132.01 - $190.29 $318,804 - $459,550	2,415 Added 4.61%	54,803 $8.04 Million
Q3 2021 Nov 02, 2021	BUY	$132.13 - $177.45 $166,880 - $224,119	1,263 Added 2.47%	52,388 $9.27 Million
Q2 2021 Aug 02, 2021	BUY	$144.0 - $179.73 $1.89 Million - $2.36 Million	13,125 Added 34.54%	51,125 $8.26 Million
Q1 2021 May 11, 2021	SELL	$158.92 - $221.61 $1.1 Million - $1.54 Million	-6,930 Reduced 15.42%	38,000 $6.51 Million
Q4 2020 Feb 08, 2021	BUY	$162.05 - $240.27 $648,200 - $961,080	4,000 Added 9.77%	44,930 $9.87 Million
Q3 2020 Nov 05, 2020	BUY	$113.26 - $167.27 $818,869 - $1.21 Million	7,230 Added 21.45%	40,930 $6.8 Million
Q2 2020 Aug 07, 2020	BUY	$72.01 - $120.39 $568,879 - $951,081	7,900 Added 30.62%	33,700 $3.85 Million
Q1 2020 May 06, 2020	BUY	$69.78 - $116.21 $90,714 - $151,073	1,300 Added 5.31%	25,800 $1.98 Million
Q4 2019 Feb 05, 2020	SELL	$70.76 - $128.86 $275,964 - $502,554	-3,900 Reduced 13.73%	24,500 $3.16 Million
Q3 2019 Nov 07, 2019	BUY	$77.91 - $109.6 $218,148 - $306,880	2,800 Added 10.94%	28,400 $2.21 Million
Q2 2019 Aug 09, 2019	BUY	$59.49 - $104.71 $309,348 - $544,492	5,200 Added 25.49%	25,600 $2.64 Million
Q4 2018 Feb 08, 2019	SELL	$32.0 - $47.43 $64,000 - $94,860	-2,000 Reduced 8.93%	20,400 $865,000
Q3 2018 Nov 07, 2018	BUY	$47.1 - $62.7 $103,620 - $137,940	2,200 Added 10.89%	22,400 $1.06 Million
Q2 2018 Aug 10, 2018	BUY	$26.05 - $52.4 $526,210 - $1.06 Million	20,200 New	20,200 $996,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account